73 related articles for article (PubMed ID: 9421248)
1. Further study of the therapy for fibrous dysplasia is necessary.
Czerwiec FS; Collins M; Feuillan P; Shenker A
J Bone Miner Res; 1997 Dec; 12(12):2128-30. PubMed ID: 9421248
[No Abstract] [Full Text] [Related]
2. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
Chapurlat R; Meunier PJ
Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate therapy for fibrous dysplasia.
DiMeglio LA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():440-5. PubMed ID: 17982393
[TBL] [Abstract][Full Text] [Related]
4. Effect of tiludronate in fibrous dysplasia of bone. A case-report.
Balblanc JC; Vignon E
Rev Rhum Engl Ed; 1999 Dec; 66(12):748-50. PubMed ID: 10649614
[No Abstract] [Full Text] [Related]
5. The nonsurgical treatment of fibrous dysplasia.
Chapurlat R; Meunier PJ
Rev Rhum Engl Ed; 1999 Jan; 66(1):1-3. PubMed ID: 10036690
[No Abstract] [Full Text] [Related]
6. [Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects].
Egner-Höbarth S; Welkerling H; Windhager R
Orthopade; 2007 Feb; 36(2):124, 126-30. PubMed ID: 17277960
[TBL] [Abstract][Full Text] [Related]
7. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density.
Weinstein RS
J Bone Miner Res; 1997 Aug; 12(8):1314-5. PubMed ID: 9258763
[No Abstract] [Full Text] [Related]
8. Medical therapy of children with fibrous dysplasia.
Glorieux FH; Rauch F
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P110-3. PubMed ID: 17228998
[No Abstract] [Full Text] [Related]
9. Bisphosphonate treatment of pediatric bone disease.
Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
[TBL] [Abstract][Full Text] [Related]
10. Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome.
O'Sullivan M; Zacharin M
J Pediatr Orthop; 2002; 22(2):255-60. PubMed ID: 11856942
[TBL] [Abstract][Full Text] [Related]
11. Fibrous dysplasia of bone and McCune-Albright syndrome.
Chapurlat RD; Orcel P
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate treatment in craniofacial fibrous dysplasia--a case report and review of the literature.
Mäkitie AA; Törnwall J; Mäkitie O
Clin Rheumatol; 2008 Jun; 27(6):809-12. PubMed ID: 18247080
[TBL] [Abstract][Full Text] [Related]
13. Alternative indications for bisphosphonate therapy.
Landesberg R; Eisig S; Fennoy I; Siris E
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):27-34. PubMed ID: 19371812
[TBL] [Abstract][Full Text] [Related]
14. Current pharmacological treatment for fibrous dysplasia and perspectives for the future.
Chapurlat R
Joint Bone Spine; 2005 May; 72(3):196-8. PubMed ID: 15850988
[No Abstract] [Full Text] [Related]
15. Intravenous Bisphosphonate Therapy as a Rescue Analgesic in Refractory Fibrous Dysplasia.
Hatcher L; Henry N; Hooten WM; D'Souza RS
Pain Med; 2022 Dec; 23(12):2085-2089. PubMed ID: 35652736
[No Abstract] [Full Text] [Related]
16. Fibrous dysplasia. Clinical review and therapeutic management.
Florez H; Peris P; Guañabens N
Med Clin (Barc); 2016 Dec; 147(12):547-553. PubMed ID: 27765282
[TBL] [Abstract][Full Text] [Related]
17. Steroid-induced visual recovery in fibrous dysplasia.
Arroyo JG; Lessell S; Montgomery WW
J Clin Neuroophthalmol; 1991 Dec; 11(4):259-61. PubMed ID: 1838545
[TBL] [Abstract][Full Text] [Related]
18. [DRUG CORRECTION OF THE STRUCTURAL AND FUNCTIONAL STATUS OF BONE TISSUE IN PATIENTS WITH FIBROUS DYSPLASIA].
Guk Y; Zyma A; Kincha-Polishchuk T; Chewerda A; Skuratov O
Georgian Med News; 2021; (316-317):46-52. PubMed ID: 34511443
[TBL] [Abstract][Full Text] [Related]
19. Intravenous calcitriol can increase bone mass in hemodialysis patients with osteitis fibrosa.
Akiba T; Kurihara S; Yamada T; Ogasawara M; Yoneshima H; Marumo F
Miner Electrolyte Metab; 1995; 21(1-3):109-13. PubMed ID: 7565429
[TBL] [Abstract][Full Text] [Related]
20. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone.
Collins MT; Kushner H; Reynolds JC; Chebli C; Kelly MH; Gupta A; Brillante B; Leet AI; Riminucci M; Robey PG; Bianco P; Wientroub S; Chen CC
J Bone Miner Res; 2005 Feb; 20(2):219-26. PubMed ID: 15647815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
